Van Diest Capital’s Merck MRK Stock Holding History

Van Diest Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+1,892	New	+$221K	0.22%	146

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Van Diest Capital's MRK Position: Q2 2026 in Review

Van Diest Capital opened a new position in Merck (MRK) in Q2 2026: 1,892 shares worth $243K. The stake represents 0.22% of the portfolio and ranks #146 among its holdings.

3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Van Diest Capital held 1,892 shares of Merck worth $243K as of Q2 2026.
Merck was a new Van Diest Capital position in Q2 2026.
Merck made up 0.22% of Van Diest Capital's portfolio in Q2 2026, its #146 holding.
3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.